These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37987388)

  • 1. An EMR-Based Approach to Determine Frequency, Prescribing Pattern, and Characteristics of Patients Receiving Drugs with Pharmacogenomic Guidelines.
    MacKinnon GE; Mills M; Stoddard A; Urrutia RA; Broeckel U
    Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
    Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Sakon C; Alicea LA; Patacca H; Brown CD; Skaar TC; Tillman EM
    Pediatr Pulmonol; 2022 Apr; 57(4):903-907. PubMed ID: 34967155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 7. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
    Deb S; Hopefl R; Reeves AA; Cvetkovic D
    Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
    Bright D; Worley M; Porter BL
    Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
    Lteif C; Eddy E; Terrell J; Cavallari LH; Malaty J; Duarte JD
    Clin Transl Sci; 2024 Jan; 17(1):e13692. PubMed ID: 38013396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
    Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
    J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
    Socco S; Wake DT; Lee JC; Dunnenberger HM
    Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
    Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
    Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.
    Liu D; Olson KL; Manzi SF; Mandl KD
    Genet Med; 2021 Apr; 23(4):782-786. PubMed ID: 33420348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
    Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG
    Front Genet; 2021; 12():712602. PubMed ID: 34745204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
    Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
    Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of population-level pharmacogenetic actionability in Alabama.
    Davis BH; Williams K; Absher D; Korf B; Limdi NA
    Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.